Allist Pharmaceuticals, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Shanghai China (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2016
NCT02973763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Allist Pharmaceuticals, Inc. | Shanghai Allist Pharmaceutical Technology Co., Ltd.